4//SEC Filing
BELINGARD JEAN-LUC 4
Accession 0001127602-20-006926
CIK 0000920148other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 3:52 PM ET
Size
8.7 KB
Accession
0001127602-20-006926
Insider Transaction Report
Form 4
BELINGARD JEAN-LUC
Director
Transactions
- Exercise/Conversion
Common Stock
2020-02-19$77.19/sh+3,100$239,289→ 41,161 total - Sale
Common Stock
2020-02-19$189.76/sh−26,479$5,024,750→ 14,682 total - Exercise/Conversion
Non-qualified Stock Options
2020-02-19−3,100→ 0 totalExercise: $77.19From: 2011-05-12Exp: 2020-05-12→ Common Stock (3,100 underlying)
Footnotes (3)
- [F1]The price of $189.7636 per share represents a weighted average of sales prices ranging from $189.54 to $189.917 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- [F3]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
Documents
Issuer
LABORATORY CORP OF AMERICA HOLDINGS
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001200845
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 3:52 PM ET
- Size
- 8.7 KB